Eli Lilly will invest $450 million into its Research Triangle Park facility in North Carolina to boost manufacturing for its diabetes products, the company announced Tuesday.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2025,